Vivoo, a passive remote monitoring platform provider, has introduced a new at-home testing kit for urinary tract infections (UTIs) at CES 2024. The new offering will be available to consumers by Q2 2024 via Amazon and other channels, although pricing details remain undisclosed.
The key features of the new diagnosis tool include the use of a urine strip and Vivoo's mobile app for immediate results, the utilization of deep learning to ensure speed and accuracy, and the digitalization of test results for easier connection with healthcare providers. Further, the company has also introduced vaginal pH tests.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.